Asmis, L M <br/><br/>
Rivaroxaban: Quantification by anti-FXa assay and influence on coagulation tests: a study in 9 Swiss laboratories.  [electronic resource] 

 -  Thrombosis research  Apr 2012 
 - 492-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1879-2472 
<br/><br/><label>Standard No.: </label>10.1016/j.thromres.2011.06.031  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anticoagulants--blood<br/>Artifacts<br/>Blood Coagulation Tests--methods<br/>Drug Monitoring--methods<br/>Factor Xa Inhibitors<br/>Humans<br/>Male<br/>Morpholines--blood<br/>Reproducibility of Results<br/>Rivaroxaban<br/>Sensitivity and Specificity<br/>Switzerland<br/>Thiophenes--blood